<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230316057732N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-05-30</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of using High Transcutaneous Electrical Nerve Stimulation on the severity of pain, nausea and vomiting after Percutaneous Nephrolithotomy</public_title>
      <acronym></acronym>
      <scientific_title>The Effect of using High Transcutaneous Electrical Nerve Stimulation on the severity of pain, nausea and vomiting after Percutaneous Nephrolithotomy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-05-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>72</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/69240</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: This is done when eligible patients are eligible to enter the study based on the form Entry and exit criteria of the study, by random allocation method and using the permutation block method in three groups Control, test and placebo were included. In the replacement block method, according to the sample size, blocks of 3 people with Three codes A, B, C were defined and considering all possible substitutions, finally 6 substitutions and 24 The block was obtained. Patients according to the time of entering the ward after the surgery is done by block method They were placed in one of the control, test or placebo groups. For example, in the first ABC block people based on the time of entering the ward after surgery in the test group and the second person in the placebo group and no The third was placed in the control group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Kidney stones. Condition 2: Nausea and vomiting. Condition 3: Pain.</hc_freetext>
      <i_freetext>Intervention group:  High Transcutaneous Electrical Nerve Stimulation In such a way that when admitting the patient in the ward, immediately after the patient's statement of pain, the intensity of pain and the intensity of nausea are evaluated and recorded using the relevant criteria. Then, the patient's skin at the location of the electrodes is cleaned with cotton dipped in alcohol and warm water for any secretions and grease, after that the electrodes are covered with disposable wet pads with a double layer with a one-sided layer covered with leather to prevent loss. The current of the device is connected to a distance of 5 cm from the area of ​​nephrostomy of the kidney undergoing surgery. Tens therapy was established for 20 minutes with a frequency of 100 Hz and the intensity of the current was based on the patient's tolerance. Then, immediately after turning off the device and at one and two hours, the severity of the patient's nausea is evaluated with a scaleAfter 6 hours, again after evaluating the intensity of pain and intensity of nausea, tennis therapy is established for 20 minutes with frequency of 100 Hz and intensity of current according to the patient's tolerance, and after turning off the device and at 7th, 8th, 12th and 18th hours, the intensity is again increased. Pain and severity of nausea are evaluated.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data is potentially shareable after de-identifying individuals

When:
The access period starts 6 months after the results are published

To whom:
All person

Conditions:
All researchers can perform the required analyzes under the condition of observing research ethics

Where to obtain:
Reza saberani
dr.rsaber@gmail.com

How to obtain:
After sending the request by email to the responsible author Reza Sabrani

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Reza Saberani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 135 baharestan 5 north khayam</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9199683342</zip>
        <telephone>+98 51 3706 0439</telephone>
        <email>Dr.rsaber@gmail.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Reza Saberani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 135 baharestan 5 north khayam</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9199683342</zip>
        <telephone>+98 51 3706 0439</telephone>
        <email>Dr.rsaber@gmail.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Consent to conduct the study
Patients who are fully awake
Patients aged 15 to 70 years
Patients undergoing unilateral percutaneous kidney stone surgery
Ability to understand and speak Persian</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Using a different anesthesia protocol than other patients
Receive anti-nausea in recovery
movement disorder
Having a digestive disease that causes vomiting and nausea
Patients with mental retardation
suffering from the mental illness or epilepsy
Pregnancy
Having cardiac arrhythmia and having a pacemaker
Any wound and deformity at the place of placement of electrodes
Diabetic neuropathy neuralgia
History of use and familiarity with TENS
Receiving narcotics or anti-nausea medication before surgery
Addiction to drugs or opium
Blindness or visual impairment</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N20.0</hc_code>
      <hc_code>R11</hc_code>
      <hc_code>R52</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Calculus of kidney</hc_keyword>
      <hc_keyword>Nausea and vomiting</hc_keyword>
      <hc_keyword>Pain, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:  High Transcutaneous Electrical Nerve Stimulation In such a way that when admitting the patient in the ward, immediately after the patient's statement of pain, the intensity of pain and the intensity of nausea are evaluated and recorded using the relevant criteria. Then, the patient's skin at the location of the electrodes is cleaned with cotton dipped in alcohol and warm water for any secretions and grease, after that the electrodes are covered with disposable wet pads with a double layer with a one-sided layer covered with leather to prevent loss. The current of the device is connected to a distance of 5 cm from the area of ​​nephrostomy of the kidney undergoing surgery. Tens therapy was established for 20 minutes with a frequency of 100 Hz and the intensity of the current was based on the patient's tolerance. Then, immediately after turning off the device and at one and two hours, the severity of the patient's nausea is evaluated with a scaleAfter 6 hours, again after evaluating the intensity of pain and intensity of nausea, tennis therapy is established for 20 minutes with frequency of 100 Hz and intensity of current according to the patient's tolerance, and after turning off the device and at 7th, 8th, 12th and 18th hours, the intensity is again increased. Pain and severity of nausea are evaluated</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain reduction. Timepoint: Before tens, immediately after the intervention of the first tens, the first hour after that, the second hour, the sixth hour, immediately after the second tens, the seventh hour, the eighth hour, the twelfth hour, the eighteenth hour. Method of measurement: Visual analogue scale.</prim_outcome>
      <prim_outcome>Severity of nausea. Timepoint: Before tens, immediately after the intervention of the first tens, the first hour after that, the second hour, the sixth hour, immediately after the second tens, the seventh hour, the eighth hour, the twelfth hour, the eighteenth hou. Method of measurement: Visual analogue scale.</prim_outcome>
      <prim_outcome>Number of Vomiting. Timepoint: Within 18 hours after surgery. Method of measurement: Visual analogue scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-04-11</approval_date>
        <contact_name>Ethics in research committee of medicine school of medical university of mashhad</contact_name>
        <contact_address>Vakil abad Blvd medical university of mashhad Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
